NCT04869501 2023-04-28Expanded Access Study of TJ004309 in Patients With Advanced or Metastatic CancerI-Mab Biopharma US LimitedNo longer available
NCT02589717 2016-11-02An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing ChemotherapyGenentech, Inc.Approved for marketing